Antifungals
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
87
NCT04921254
A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005.
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 23, 2021
Completion: May 31, 2023
NCT06678113
Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal Infection
Phase: Phase 1/2
Start: Jul 1, 2024
Completion: Apr 1, 2026
Loading map...